Concepedia

Vladimir Voynov

VV

Statistics

Publications

15

Citations

1.7K

H-Index

15

Active since

2006

Affiliations

Massachusetts Institute of Technology(Current)

Novartis (Switzerland)

Boehringer Ingelheim (Spain)

Boehringer Ingelheim (Austria)

Boehringer Ingelheim (Brazil)

Vladimir Voynov is an author at Massachusetts Institute of Technology specializing in medicine, antibody engineering, and systems biology.

ORCID

Top concepts

Publications per year

2006–2022

15

Publications

15

Design of therapeutic proteins with enhanced stability

Naresh Chennamsetty, Vladimir Voynov, Veysel Kayser et al. · Proceedings of the National Academy of Sciences · 2009 · 586 citations · Full text

, , +15

Prediction of Aggregation Prone Regions of Therapeutic Proteins

Naresh Chennamsetty, Vladimir Voynov, Veysel Kayser et al. · The Journal of Physical Chemistry B · 2010 · 201 citations

Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies

Veysel Kayser, Naresh Chennamsetty, Vladimir Voynov et al. · Biotechnology Journal · 2010 · 163 citations

Aggregation-Prone Motifs in Human Immunoglobulin G

Naresh Chennamsetty, Bernhard Helk, Vladimir Voynov et al. · Journal of Molecular Biology · 2009 · 152 citations

, , +7

Evaluation of a Non-Arrhenius Model for Therapeutic Monoclonal Antibody Aggregation

Veysel Kayser, Naresh Chennamsetty, Vladimir Voynov et al. · Journal of Pharmaceutical Sciences · 2011 · 115 citations

, , +11

1–5 of 15